| Symbol | PROF |
|---|---|
| Name | PROFOUND MEDICAL CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 2400 SKYMARK AVENUE,UNIT 6, MISSISSAUGA, Ontario, L4W 5K5, Canada |
| Telephone | +1 647 - 476-1350 |
| Fax | — |
| — | |
| Website | https://www.profoundmedical.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001628808 |
| Description | Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare systems existing imaging infrastructure. The companys product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customers existing MRI scanner. Additional info from NASDAQ: |
(80% Positive) PROFOUND MEDICAL CORP. (PROF) Provides Update on Clinic for Florida
Read moreProfound to ShowcaseTULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
Read moreNew Form S-3 - Profound Medical Corp. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001104659-26-059487 <b>Size:</b> 365 KB
Read more(90% Positive) PROFOUND MEDICAL CORP. (PROF) Reports Q2 2026 Financial Results
Read more(99% Neutral) PROFOUND MEDICAL CORP. (PROF) Provides Update on innovator for interventional MRI procedures
Read moreProfound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
Read more(99% Neutral) PROFOUND MEDICAL CORP. (PROF) Provides Update on Participate for real time
Read moreProfound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Read more